Increased Incidence of Resistant Hypertension in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study

作者: Jocelyn S. Gandelman , Omair A. Khan , Megan M. Shuey , Jacquelyn E. Neal , Elizabeth McNeer

DOI: 10.1002/ACR.23880

关键词:

摘要: OBJECTIVE To compare the risk of resistant hypertension (RHTN) in patients with systemic lupus erythematosus (SLE) and controls without SLE, to define factors associated RHTN SLE. METHODS We studied 1,044 SLE 5,241 control subjects using de-identified electronic health records from a tertiary care center. was defined as ≥4 International Classification Diseases, Ninth Revision codes for antinuclear antibody titer ≥1:160. uncontrolled blood pressure on 3 antihypertensive medications or requiring 4 more antihypertensives attain control. First, we compared between groups. Second, examined association all-cause mortality RESULTS nearly twice prevalent (10.2% 5.3%, respectively), an incidence rate 10.2 versus 6.1 cases per 1,000 person-years observation (hazard ratio [HR] 1.72 [95% confidence interval 1.28-2.30]; P < 0.001, adjusted age, sex, race, baseline end-stage renal disease [ESRD], creatinine, calendar year). In found associations black lower function, hypercholesterolemia, increased inflammatory markers. significantly higher (HR 2.91, = 0.0005) after adjustment year, ESRD, number visits. CONCLUSION Patients have frequency-matched controls, independent multiple covariates. is important comorbidity clinicians recognize because it mortality.

参考文章(41)
A. B. Lee, T. Godfrey, K. G. Rowley, C. S. Karschimkus, G. Dragicevic, E. Romas, L. Clemens, A. M. Wilson, M. Nikpour, D. L. Prior, J. D. Best, A. J. Jenkins, Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus Internal Medicine Journal. ,vol. 36, pp. 237- 243 ,(2006) , 10.1111/J.1445-5994.2006.01044.X
Janice P. Lea, Lupus Nephritis in African Americans The American Journal of the Medical Sciences. ,vol. 323, pp. 85- 89 ,(2002) , 10.1097/00000441-200202000-00005
DM Roden, JM Pulley, MA Basford, GR Bernard, EW Clayton, JR Balser, DR Masys, Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clinical Pharmacology & Therapeutics. ,vol. 84, pp. 362- 369 ,(2008) , 10.1038/CLPT.2008.89
Margaret T. Hicken, Hedwig Lee, Jeffrey Morenoff, James S. House, David R. Williams, Racial/Ethnic Disparities in Hypertension Prevalence: Reconsidering the Role of Chronic Stress American Journal of Public Health. ,vol. 104, pp. 117- 123 ,(2014) , 10.2105/AJPH.2013.301395
Rosa M. Andrade, Graciela S. Alarcón, Mónica Fernández, Mandar Apte, Luis M. Vilá, John D. Reveille, , Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis & Rheumatism. ,vol. 56, pp. 622- 630 ,(2007) , 10.1002/ART.22375
Pantelis A. Sarafidis, Panagiotis Georgianos, George L. Bakris, Resistant hypertension—its identification and epidemiology Nature Reviews Nephrology. ,vol. 9, pp. 51- 58 ,(2013) , 10.1038/NRNEPH.2012.260
Johanna T. Gustafsson, Elisabet Svenungsson, Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Autoimmunity. ,vol. 47, pp. 67- 76 ,(2014) , 10.3109/08916934.2013.856005
C. P Chung, I. Avalos, A. Oeser, T. Gebretsadik, A. Shintani, P. Raggi, C Michael Stein, High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Annals of the Rheumatic Diseases. ,vol. 66, pp. 208- 214 ,(2006) , 10.1136/ARD.2006.054973
Terri Levien, Advances in the treatment of Raynaud's phenomenon. Vascular Health and Risk Management. ,vol. 6, pp. 167- 177 ,(2010) , 10.2147/VHRM.S4551